- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03917927
A Clinical Study of the Eztetic Dental Implant System (RoseQuartz)
January 24, 2024 updated by: ZimVie
A Prospective Multicenter Study of the Integration Success of the Eztetic Dental Implant System in Immediate Loading Cases
This will be a prospective, observational multicenter study.
All implants will be placed in the anterior maxilla or mandible and immediately loaded with a provisional prosthesis out of occlusion.
Final restorations insertion will take place no later than 6 months following implant placement surgery.
All implants will be restored with a single crown or splinted to a pre-existing implant if in the pre-molar region (no 2 adjacent edentulous sites).
Study Overview
Detailed Description
This will be a prospective, observational study in which patients in need of dental implants in the anterior regions of the maxilla or mandible will be treated with the Eztetic dental implant(s).
Qualified patients will be those with one or more edentulous area in the anterior maxilla or mandible needing a single (restored as a single crown; if in the pre-molar region, it is recommended implant be splinted to another tooth or implant; no 2 adjacent edentulous sites).
Qualified patients should have presence of posterior teeth or a stable posterior occlusion.
All implants will be placed in a single-stage manner.
A provisional abutment will be placed and a temporary crown will be placed (cemented or screw-retained) out of occlusion at implant placement surgery visit.
Impressions for permanent prosthesis fabrication will take place at 6 weeks and prosthesis placement will take place at 2 months.
Final prosthesis insertion will take place no later than 6 months following implant placement surgery.
Resonance frequency assessment procedures will be done at implant placement surgery and at prosthesis insertion.
Implant survival will be the primary study endpoint.
Crestal bone regression will be the secondary study endpoint.
Enrollment will continue until 20 patients have completed final prosthetic treatment at study center.
Study Type
Interventional
Enrollment (Actual)
82
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Santiago, Chile
- San Jose Hospital
-
-
-
-
-
Mainz, Germany, 55128
- Dr. Tasso-Eyke von Haussen
-
-
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- Ohio State University
-
-
Virginia
-
Richmond, Virginia, United States, 23298-0566
- Virginia Commonwealth University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients of either sex and at least 18 years of age
- Patients for whom a decision has already been made to use a dental implant for the restoration of existing partial edentulism in the anterior (central and lateral incisors), canine or pre-molar regions in the mandible or maxilla. Placing implant in canine region should be in a healed site (not for immediate extraction)
- Immediate extraction or a prior extracted site
- Intact buccal table as verified by Cone Beam Computed Tomography (CBCT) or radiography during surgery. If absent, patient should be excluded from enrollment in the study.
- Patients must be physically able to tolerate conventional surgical and restorative procedures.
- Patients with a facial lingual width of at least 5.1mm and inner tooth width of at least 6mm.
- Patients having a thick gingival biotype (based on the lack of transparency of the periodontal probe through the gingival margin while probing the buccal sulcus) will be preferred but lack of this characteristic will not disqualify a patient from inclusion in this study.
- Presence of opposing dentition with a functional occlusion that permits the restoration with a non-occluding provisional prosthesis.
- Patients who provide a signed informed consent; a patient having implant placement surgery will continue participation in the study regardless of whether or not they receive restorative treatment according to protocol (protocol deviation)
- Patients who agree to be evaluated for each study visit.
- Minimum primary stability, insertion torque > 35Ncm (this will be a criteria that is met at the time of surgery)
Exclusion Criteria:
- Patients with known systemic diseases such as uncontrolled diabetes, endocrine disease, heart disease, immuno-compromised, or mental disorders.
- Patients with current use of non-steroidal anti-inflammatory drugs, bisphosphonates or corticosteroid treatments.
- Patients with active infection or severe inflammation in the areas intended for implant placement.
- Prisoners
- Patients with a > 10 cigarette per day smoking habit.
- Patients with a history of therapeutic radiation to the head or jaw.
- Patients in need of bone grafting at the site of the intended implantation site(s).
- Patients who are known to be pregnant at the screening visit or planning to become pregnant within 6 months of study enrollment.
- Patients with evidence of severe parafunctional habits such as bruxing or clenching.
- Patients with HIV or Hepatitis infection
- Patients who have previously failed implants at the site intended for study implant placement
- Patients in need of other treatments or surgeries at a site adjacent to the intended implantation site
- Patients with a history of severe periodontal disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Eztetic dental implant
Eztetic 3.1mm diameter, lengths 8, 10, 11.5, 13, 16 mm
|
narrow diameter dental implant
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Implant survival
Time Frame: 2 years
|
survival (no declaration of failure) of dental implant
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Marginal bone changes
Time Frame: 2 years
|
Change in bone levels around dental implant
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Burak Yilmaz, DDS, Ohio State University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 8, 2019
Primary Completion (Actual)
May 30, 2023
Study Completion (Actual)
January 22, 2024
Study Registration Dates
First Submitted
April 13, 2019
First Submitted That Met QC Criteria
April 13, 2019
First Posted (Actual)
April 17, 2019
Study Record Updates
Last Update Posted (Estimated)
January 25, 2024
Last Update Submitted That Met QC Criteria
January 24, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1601 (University Hospital Bern)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Edentulous Jaw
-
Dentsply Sirona Implants and ConsumablesCompletedPartially Edentulous JawChina
-
University of Alabama at BirminghamZimmer DentalCompleted
-
Dentsply Sirona Implants and ConsumablesCompletedPartially Edentulous JawChina
-
Dentsply Sirona Implants and ConsumablesCompletedPartially Edentulous JawChina
-
Dentsply Sirona Implants and ConsumablesCompleted
-
Dentsply Sirona Implants and ConsumablesCompleted
-
University of IowaEnrolling by invitationEdentulous Jaw | Edentulous MouthUnited States
-
Concordia Dent SrlITI International Team for Implantology, SwitzerlandCompletedMANDIBLE | ATROPHYC EDENTULOUS JAWRomania
-
University of Roma La SapienzaCompletedEdentulous Patients
-
Cairo UniversityUnknownEdentulous Alveolar Ridge | Edentulous Jaw | Edentulous MouthEgypt
Clinical Trials on Eztetic dental implant
-
ZimVieCompletedPartial Edentulism | Tooth DiseaseUnited States
-
University of Alabama at BirminghamZimmer DentalCompleted
-
Cairo UniversityRecruitingHorizontal Atrophy of Edentulous Alveolar RidgeEgypt
-
Cairo UniversityUnknown
-
Aula Dental AvanzadaCompletedDental Implant Failed | Dental Prosthesis FailureSpain
-
The University of Hong KongRecruitingDental Implant Failed | Dental Implants | Single Tooth LostGermany, Hong Kong
-
Institut Straumann AGAvaniaActive, not recruitingDental Implants, Single-ToothGermany, Hong Kong, Portugal
-
Universidad de GranadaCompletedJaw, Edentulous, PartiallySpain
-
Aula Dental AvanzadaRecruiting
-
Federal University of Rio Grande do SulRecruiting